ADENURIC

This brand name is authorized in Australia, Austria, Croatia, Cyprus, Estonia, Finland, France, Germany, Ireland, Italy, Lithuania, Netherlands, New Zealand, Poland, Romania, Spain, Turkey, UK.

Active ingredients

The drug ADENURIC contains one active pharmaceutical ingredient (API):

1	Febuxostat UNII 101V0R1N2E - FEBUXOSTAT
	Uric acid is the end product of purine metabolism in humans and is generated in the cascade of hypoxanthine → xanthine → uric acid. Both steps in the above transformations are catalyzed by xanthine oxidase (XO). Febuxostat is a 2-arylthiazole derivative that achieves its therapeutic effect of decreasing serum uric acid by selectively inhibiting XO.
	Read more about Febuxostat

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
ADENURIC Film-coated tablet	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
M04AA03	Febuxostat	M Musculo-skeletal system → M04 Antigout preparations → M04A Antigout preparations → M04AA Preparations inhibiting uric acid production
Discover more medicines within M04AA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	10445R
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	05455113, 05455136, 05455142, 05455159, 10078397, 10078405, 10261256, 11015683, 11073835, 11073841, 11479721, 11853444, 11853450, 11893768, 13902980, 13902997, 13971857, 14227405, 14260561, 14260578, 14267103, 15373592, 15373600, 15529545, 15563134, 15563140, 17161322, 17161339, 17969225
EE	Ravimiamet	1349287, 1349298, 1349300, 1349311, 1492961, 1492972, 1492983, 1492994, 1493007, 1493018, 1493029, 1493030
ES	Centro de información online de medicamentos de la AEMPS	08447001, 08447003
FI	Lääkealan turvallisuus- ja kehittämiskeskus	101845, 168329
FR	Base de données publique des médicaments	61871331, 64493890
GB	Medicines & Healthcare Products Regulatory Agency	170310, 170312, 299543, 374287, 376203, 381148, 381150
IE	Health Products Regulatory Authority	65600, 65601, 65602
IT	Agenzia del Farmaco	039538018, 039538032
LT	Valstybinė vaistų kontrolės tarnyba	1032555, 1032556, 1032557, 1032558, 1063623, 1063624, 1063625, 1063626, 1063627, 1063628, 1063629, 1063630, 1079546, 1079547, 1079548, 1079549, 1079550, 1079551, 1079552, 1079553, 1079554, 1079555, 1079556, 1079557
NL	Z-Index G-Standaard, PRK	101788, 101796
NZ	Medicines and Medical Devices Safety Authority	15660, 15673
PL	Rejestru Produktów Leczniczych	100221962, 100221985
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W57781001, W57781002, W57781003, W57782001, W57782002, W57782003
TR	İlaç ve Tıbbi Cihaz Kurumu	8699832090598, 8699832090604